ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 865,32
-0,41%
Dow Jones
44 933,80
0,19%
DAX
21 632,37
0,90%
Brent Oil
76,415
-0,25%
Bitcoin
102 291,13
0,95%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Longeveron Inc (LGVN) Cours

Longeveron Inc

Longeveron Inc (LGVN)

NASDAQ
1,571
-0,029
( -1,81% )
Mis à jour : 15:51:44
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
1,571
Prix Achat
1,57
Prix Vente
1,59
Volume échangé
10 760
1,571 Fourchette du Jour 1,599
0,7707 Plage de 52 semaines 7,9059
Cap du marché
23,309M
Clôture Veille
1,60
Ouverture
1,58
Dernière Transaction
5
@
1.58
Dernière heure de transaction
15:51:46
Volume financier
US$ 17 075
VWAP
1,5869
Volume moyen (3 m)
333 892
Actions en circulation
14 836 775
Rendement du Dividende
-
Ratio Cours sur Bénéfices
0,00
Bénéfice par action (BPA)
-
Chiffre d'affairess
709k
Bénéfice net
-22,21M

À propos de Longeveron Inc

Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, Metabolic Syndrome, Acute Respiratory Distress Syndrome ... Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Hypoplastic left heart syndrome (HLHS). Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
/www.longeveron.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Longeveron Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker LGVN. Le dernier cours de clôture d'Longeveron était de US$1,60. Au cours de la dernière année, les actions de Longeveron ont été négociées dans une fourchette de prix de US$ 0,7707 à US$ 7,9059.

Longeveron compte actuellement 14 836 775 actions en circulation. La capitalisation boursière d'Longeveron est de US$23,74 million.

LGVN Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

07 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

07 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

07 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

07 Janvier 2025
Edgar (US Regulatory)

Longeveron to Present at Biotech Showcase 2025

MIAMI, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and...

18 Décembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

12 Novembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

12 Novembre 2024
Edgar (US Regulatory)

Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update

Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ in rare pediatric disease HLHS has achieved more than 80% enrollmentPositive Type C meeting with U.S. FDA confirmed ELPIS II is pivotal...

12 Novembre 2024
GlobeNewswire Inc.

Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC)

MIAMI, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and...

11 Novembre 2024
GlobeNewswire Inc.

Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024

MIAMI, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and...

04 Novembre 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.249-13.68131868131.821.831.551591521.6331765CS
4-0.219-12.23463687151.792.241.552677671.82953063CS
12-0.699-30.79295154192.272.311.553338921.92810698CS
26-2.499-61.40049140054.074.291.557597562.60156021CS
52-5.929-79.05333333337.57.90590.770734837692.99427797CS
156-67.429-97.723188405869167.70.7707169814937.80479713CS
260-13.229-89.385135135114.84500.7707199407092.45860717CS

LGVN - Frequently Asked Questions (FAQ)

What is the current Longeveron share price?
The current share price of Longeveron is US$ 1,571
How many Longeveron shares are in issue?
Longeveron has 14 836 775 shares in issue
What is the market cap of Longeveron?
The market capitalisation of Longeveron is USD 23,74M
What is the 1 year trading range for Longeveron share price?
Longeveron has traded in the range of US$ 0,7707 to US$ 7,9059 during the past year
What is the reporting currency for Longeveron?
Longeveron reports financial results in USD
What is the latest annual turnover for Longeveron?
The latest annual turnover of Longeveron is USD 709k
What is the latest annual profit for Longeveron?
The latest annual profit of Longeveron is USD -22,21M
What is the registered address of Longeveron?
The registered address for Longeveron is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Longeveron website address?
The website address for Longeveron is /www.longeveron.com
Which industry sector does Longeveron operate in?
Longeveron operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
OCEAOcean Biomedical Inc
US$ 0,5155
(56,21%)
96,91M
SLXNSilexion Therapeutics Corporation
US$ 2,005
(48,52%)
94,13M
SPGCSacks Parente Golf Inc
US$ 0,559047
(47,12%)
11,01M
SXTP60 Degrees Pharmaceuticals Inc
US$ 1,10
(42,71%)
39,58M
NVNINVNI Group Ltd
US$ 6,66
(27,59%)
13,41M
ZKINZK International Group Co Ltd
US$ 0,49
(-40,15%)
1,34M
BACKIMAC Holdings Inc
US$ 0,8339
(-31,65%)
952,5k
HAOHaoxi Health Technology Ltd
US$ 2,6206
(-29,17%)
122,69k
MGOLMGO Global Inc
US$ 0,1184
(-28,80%)
16,95M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0437
(-24,39%)
15,58M
OCEAOcean Biomedical Inc
US$ 0,5155
(56,21%)
96,91M
SLXNSilexion Therapeutics Corporation
US$ 2,005
(48,52%)
94,13M
NVDANVIDIA Corporation
US$ 125,28
(-2,88%)
49,02M
SXTP60 Degrees Pharmaceuticals Inc
US$ 1,10
(42,71%)
39,58M
EVTVEnvirotech Vehicles Inc
US$ 0,695201
(22,18%)
37,53M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
LGVN
Longeveron
BIT
F32163
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés